The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: Equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo

British Journal of Pharmacology

Volumn 121, Issue 3, 1997, Pages 595-603

  Malmström, Rickard E ^a   Balmér, Karin C ^b   Lundberg, Jan M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

BIBP 3226; Endogenous and exogenous NPY; NPY Y1 receptor antagonist

Indexed keywords

NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; COMPARTMENT MODEL; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HINDLIMB; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; SYMPATHETIC NERVE;

ANIMALS; ARGININE; BLOOD VESSELS; ELECTRIC STIMULATION; FEMALE; MALE; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y; SWINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0030925788     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701154     Document Type: Article

References (24)

1. BAO, J.-X. (1993). Sympathetic neuromuscular transmission in rat tail artery. Acta Physiol. Scand., 148, suppl. 610.
2. BENNETT, H.S., LUFT, J.H. & HAMPTON, J.G. (1959). Morphological classifications of vertebrate blood capillaries. Am. J. Physiol., 196, 381-390.
3. DOODS, H.N. & KRAUSE, J. (1991). Different neuropeptide Y receptor subtypes in rat and rabbit vas deferens. Eur. J. Pharmacol., 204, 101-103.
4. GRUNDEMAR, L., JONAS, S.E., MÖRNER, N., HÖGESTÄTT, E.D., WAHLESTEDT, C. & HÅKANSON, R. (1992). Characterization of vascular neuropeptide Y receptors. Br. J. Pharmacol., 105, 45-50.
5. LANGER, S.Z. & HICKS, P.E. (1984). Alpha-adrenoceptor subtypes in blood vessels: physiology and pharmacology. J. Cardiovasc. Pharmacol., 6, S547-S558.
6. 2-adrenoceptor. Trends Pharmacol. Sci., 3, 440-444.
7. LUNDBERG, J.M. (1996). Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev., 48, 113-178.
8. LUNDBERG, J.M., HEMSÉN, A., LARSSON, O., RUDEHILL, A., SARIA, A. & FREDHOLM, B.B. (1988). Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. Eur. J. Pharmacol., 145, 21-29.
9. LUNDBERG, J.M., MARTINSON, A., HEMSÉN, A., THEODORSSON-NORHEIM, E., SVEDENHAG, J., EKBLOM, B. & HJEMDAHL, P. (1985). Corelease of neuropeptide Y and catecholamines during physical exercise in man. Biochem. Biophys. Res. Commun., 133, 30-36.
10. 1 receptor antagonist BIBP 3226. Br. J. Pharmacol., 116, 2971-2982.
11. LUNDBERG, J.M., TERENIUS, L., HÖKFELT, T., MARTLING, C.-R., TATEMOTO, K., MUTT, V., POLAK, J., BLOOM, S. & GOLDSTEIN, M. (1982). Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol. Scand., 116, 477-480.
12. 1 receptor accounts for the long-lasting part of the sympathetic contraction in guinea-pig vena cava: evidence using SR 120107A. Acta Physiol. Scand., 155, 329-330.
13. MALMSTRÖM, R.E. & LUNDBERG, J.M. (1995b). Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435. Eur. J. Pharmacol., 294, 661-668.
14. 1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 633-642.
15. 1 receptor mediated sympathetic vasoconstriction in pigs in vivo. Eur. J. Pharmacol., 305, 145-154.
16. MODIN, A., PERNOW, J. & LUNDBERG, J.M. (1991). Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur. J. Pharmacol., 203, 165-171.
17. MODIN, A., PERNOW, J. & LUNDBERG, J.M. (1993a). Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs: maintained overflow of neuropeptide Y in controls but not after reserpine. J. Autonom. Nerv. Syst., 49, 123-134.
18. MODIN, A., PERNOW, J. & LUNDBERG, J.M. (1993b). Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y. Acta Physiol. Scand., 148, 1-11.
19. 1 receptor antagonist: BIBP 3226. Eur. J. Pharmacol., 271, R11-R13.
20. SERRADEIL-LE GAL, C., VALETTE, G., ROUBY, P.-E., PELLET, A., OURY-DONAT, F., BROSSARD, G., LESPY, L., MARTY, E., NELIAT, G., DE COINTET, P., MAFFRAND, J.-P. & LE FUR, G. (1995). SR 120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist. FEBS Lett., 362, 192-196.
21. SERRADEIL-LE GAL, C., VALETTE, G., ROUBY, P.E., PELLET, A., VILLANOVA, G., FOULON, L., LESPY, L., NELIAT, G., CHAMBON, J.P., MAFFRAND, J.P. & LE FUR, G. (1994). SR 120107A and SR 120819A: two potent and selective orally-effective antagonists for NPY Y1 receptors. Soc. Neurosci. Abstr., 20, 907.
22. 2 receptors for neuropeptide Y. FEBS Lett., 245, 209-214.
23. STARK, R.D. (1968). Conductance or resistance? Nature, 217, 779.
24. WAHLESTEDT, C., YANAIHARA, N. & HÅKANSON, R. (1986). Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Regul. Pept., 13, 307-318.